Home

Care for dementia patients is still not receiving the "urgency and priority" it needs almost a year after the government unveiled a national strategy, a spending watchdog said on Thursday. A lack of basic training and "patchy" joined-up working meant many older people faced unnecessary hospital stays or were put into care homes too early, the National Audit Office found ...

LONDON (Reuters) - Medicines commonly used to treat high blood pressure and heart disease may cut the risk of developing Alzheimer's disease and dementia, U.S. scientists said on Wednesday. Researchers from Boston found that older people taking a certain type of blood pressure medication known as angiotensin receptor blockers (ARBs) were significantly less likely to develop the brain-wasting illnesses ...

A widely-prescribed drug to tackle high blood pressure and heart disease also appears to reduce the risk of Alzheimer's and other forms of dementia, according to a large US study published on Wednesday. US military veterans who took angiotensin receptor blockers (ARBs) were between 19 and 24 percent less likely to develop dementia over a four-year period compared with ...

CHICAGO (Reuters) - Strong warnings about the dangers of giving antipsychotic drugs to patients with dementia have reduced use of the drugs in these patients by a "modest" 19 percent, U.S. researchers said on Monday. Studies have shown that using antipsychotic drugs shortens the lives of elderly patients with dementia. The U.S. Food and Drug Administration issued a warning ...

The herbal supplement ginkgo biloba does not slow cognitive decline, a study published Tuesday in the Journal of the American Medical Association (JAMA) said. Researchers from the University of Pittsburgh analyzed data in an eight-year randomized, double-blind placebo-controlled trial called the Ginkgo Evaluation of Memory (GEM) study, for which half of the 3,069 participants were given daily doses of ...

WASHINGTON (Reuters) - The widely used herbal supplement Ginkgo biloba does not appear to slow the rate of cognitive decline in healthy older people or those with mild cognitive impairment, U.S. researchers said on Tuesday. Their study involved 3,069 people age 72 or older from four U.S. communities who were tracked for an average of six years. Half ...

NEW YORK (Reuters Health) - People with Alzheimer's disease may be less apt to get cancer and people with cancer may be less apt to get Alzheimer's disease, new research hints. "Discovering the links between these two conditions may help us better understand both diseases and open up avenues for possible treatments," Dr. Catherine M. Roe of Washington University ...

A person's risk of contracting Alzheimer's may be linked to levels of the appetite-suppressing hormone leptin, according to a US study published Wednesday which could point the way toward future treatment of the disease. The Journal of the American Medical Association (JAMA) reported that scientists in the northeastern state of Massachusetts have found that high levels of the ...

CHICAGO (Reuters) - People who have higher levels of an appetite-suppressing hormone produced by fat cells may be less likely to develop Alzheimer's disease or dementia than others, U.S. researchers said Tuesday. They said people in a study who had the highest levels of leptin were far less likely to develop Alzheimer's disease or any sort of dementia ...

* Dementia threat growing in low and middle income nations * Study says costs "enormous," will grow as populations age By Kate Kelland LONDON (Reuters) - Dementia is the biggest cause of disability in old people in poorer countries and the problem and its costs for society will grow rapidly as populations age, doctors said on Friday. British researchers studied 15,000 elderly ...